Use of PULSAR (personalized ultra-fractionated stereotactic adaptive radiotherapy) as consolidation with immune checkpoint inhibition in the treatment of pediatric metastatic melanoma.
Saved in:
| Title: | Use of PULSAR (personalized ultra-fractionated stereotactic adaptive radiotherapy) as consolidation with immune checkpoint inhibition in the treatment of pediatric metastatic melanoma. |
|---|---|
| Authors: | McCarty KL; Division of Pediatric Hematology and Oncology, UT Southwestern Medical Center, Dallas, TX, USA. kyra.mccarty@duke.edu., Watt T; Division of Pediatric Hematology and Oncology, UT Southwestern Medical Center, Dallas, TX, USA., Dan TD; Department of Radiation Oncology, UT Southwestern Medical Center, Dallas, TX, USA., Timmerman RD; Department of Radiation Oncology, UT Southwestern Medical Center, Dallas, TX, USA., Kumar KA; Department of Radiation Oncology, UT Southwestern Medical Center, Dallas, TX, USA. |
| Source: | Radiation oncology (London, England) [Radiat Oncol] 2025 Aug 21; Vol. 20 (1), pp. 132. Date of Electronic Publication: 2025 Aug 21. |
| Publication Type: | Journal Article; Case Reports |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101265111 Publication Model: Electronic Cited Medium: Internet ISSN: 1748-717X (Electronic) Linking ISSN: 1748717X NLM ISO Abbreviation: Radiat Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
